Huel is looking for a huge exit event soon, but should the plant-based meal replacement maker go the initial public offering route or opt to sell the business? Are you familiar with Huel (which stands for Human + Fuel)? You should be if you’re an avid follower of my content because I’ve mentioned the active nutrition brand on a handful of separate occasions over the past year. These Huel mentions spanned M&A target commentary in Glanbia and MyProtein content (which I’ll drive deeper into at the end of the content), but I’ve also highlighted the nutrition brand in my functional beverage trends content this past the summer. This is where I stated the idea of “Convenience Bio-Hacking” would have market share reshuffling power in the near term. Convenience Bio-Hacking is a phrase I coined to better explain the trend concept and current phase of active nutrition (human optimization) personalized nutrition commercialization. This is exactly the cross-section of the market that Huel sits in now and it's been highly lucrative. That's why in the past week it was reported that Huel had hired bankers to advise them on a dual-track exit process through a potential sale of the business or the preferred option to fund future growth by an initial public offering on the London Stock Exchange. In this latest episode, I'll look at both options within the dual-track exit process a bit deeper and explain which direction would I hypothetically take?

FOLLOW ME ON MY SOCIAL MEDIA ACCOUNTS